Are neurological complications of monoclonal gammopathy of undetermined significance underestimated? | Zendy

Normann Steiner | Zendy; Angelika Schwärzler | Zendy; Georg Göbel | Zendy; Wolfgang N. Löscher | Zendy; Julia Wanschitz | Zendy; Eberhard Gunsilius | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?

Author(s) -

Normann Steiner,

Angelika Schwärzler,

Georg Göbel,

Wolfgang N. Löscher,

Julia Wanschitz,

Eberhard Gunsilius

Publication year - 2016

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.13861

Subject(s) - monoclonal gammopathy of undetermined significance , medicine , monoclonal gammopathy , pathology , monoclonal , immunology , monoclonal antibody , antibody

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignancy preceding multiple myeloma (MM) or related disorders. Neurological symptoms caused by the monoclonal immunoglobulins or free light-chains are often associated with a high morbidity. We analyzed the prevalence of neuropathy, clinical features and the long-term outcome in 223 patients (pts.) with MGUS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research